L-4F differentially alters plasma levels of oxidized fatty acids resulting in more anti-inflammatory HDL in mice.

Drug Metabolism Letters
Satoshi ImaizumiSrinivasa T Reddy

Abstract

To determine in vivo if L-4F differentially alters plasma levels of oxidized fatty acids resulting in more anti-inflammatory HDL. Injecting L-4F into apoE null mice resulted in a significant reduction in plasma levels of 15-HETE, 5-HETE, 13-HODE and 9-HODE. In contrast, plasma levels of 20-HETE were not reduced and plasma levels of 14,15-EET, which are derived from the cytochrome P450 pathway, were elevated after injection of L-4F. Injection of 13(S)-HPODE into wild-type C57BL/6J mice caused an increase in plasma levels of 13-HODE and 9-HODE and was accompanied by a significant loss in the anti-inflammatory properties of HDL. The response of atherosclerosis resistant C3H/HeJ mice to injection of 13(S)-HPODE was similar but much more blunted. Injection of L-4F at a site different from that at which the 13(S)-HPODE was injected resulted in significantly lower plasma levels of 13-HODE and 9-HODE and significantly less loss of HDL anti-inflammatory properties in both strains. i) L-4F differentially alters plasma levels of oxidized fatty acids in vivo. ii) The resistance of the C3H/HeJ strain to atherosclerosis may in part be mediated by a reduced reaction of this strain to these potent lipid oxidants.

Citations

Nov 9, 2010·Current Atherosclerosis Reports·Esad Vucic, Robert S Rosenson
Feb 2, 2011·Integrative Biology : Quantitative Biosciences From Nano to Macro·Feng GaoRobin Farias-Eisner
Aug 2, 2011·Journal of Lipid Research·David MeriwetherIshaiahu Shechter
Jun 2, 2011·Circulation Journal : Official Journal of the Japanese Circulation Society·Satoshi ImaizumiSrinivasa T Reddy
Jan 18, 2014·Biochemical and Biophysical Research Communications·Xinmin YanRongsong Li
Mar 7, 2014·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·C MorgantiniS T Reddy
Jul 24, 2015·European Journal of Medicinal Chemistry·Ewa D MicewiczPiotr Ruchala
Aug 26, 2015·Lipids in Health and Disease·Kexi ZhaChao Xu
Aug 20, 2011·Diabetes·Cecilia MorgantiniSrinivasa T Reddy
Mar 23, 2011·International Journal of Cancer. Journal International Du Cancer·Ekambaram GanapathyRobin Farias-Eisner
Aug 25, 2020·Rheumatology·Sangmae Sharon BaeChristina Charles-Schoeman
Feb 10, 2011·Nature Reviews. Cardiology·Mohamad NavabAlan M Fogelman
Oct 16, 2015·The Journal of Immunology : Official Journal of the American Association of Immunologists·Leland L BlackJanusz H Kabarowski
Apr 18, 2017·Free Radical Research·Markku Ahotupa
Aug 11, 2021·Current Opinion in Lipidology·Grant BarkerSrinivasa Reddy

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.